Dr. Bhave is interested in the assembly and function of basement membranes and extracellular matrix particularly in renal disease. By studying matrix biochemistry at a fundamental level, I hope to gain insight into renal glomerular and tubulointerstitial fibrosis which represents the common final pathway to injury in nearly all kidney diseases. My group utilizes cell culture systems, molecular biology, biochemistry, mass spectrometry, and mouse genetics to answer questions of interest.



The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Peroxidasin Is a Novel Target of Autoantibodies in Lupus Nephritis. Manral P, Colon S, Bhave G, Zhao MH, Jain S, Borza DB (2019) Kidney Int Rep 4(7): 1004-1006
    › Primary publication · 31317122 (PubMed) · PMC6611989 (PubMed Central)
  2. Quantitating excess tissue sodium. Bhave G (2019) Clin Sci (Lond) 133(6): 739-740
    › Primary publication · 30890651 (PubMed)
  3. DSS-induced damage to basement membranes is repaired by matrix replacement and crosslinking. Howard AM, LaFever KS, Fenix AM, Scurrah CR, Lau KS, Burnette DT, Bhave G, Ferrell N, Page-McCaw A (2019) J Cell Sci 132(7)
    › Primary publication · 30837285 (PubMed) · PMC6467488 (PubMed Central)
  4. Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model. Colon S, Luan H, Liu Y, Meyer C, Gewin L, Bhave G (2019) Am J Physiol Renal Physiol 316(2): F360-F371
    › Primary publication · 30565999 (PubMed) · PMC6397377 (PubMed Central)
  5. Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes. McCall AS, Bhave G, Pedchenko V, Hess J, Free M, Little DJ, Baker TP, Pendergraft WF, Falk RJ, Olson SW, Hudson BG (2018) J Am Soc Nephrol 29(11): 2619-2625
    › Primary publication · 30279272 (PubMed) · PMC6218858 (PubMed Central)
  6. Using Electrolyte Free Water Balance to Rationalize and Treat Dysnatremias. Shah SR, Bhave G (2018) Front Med (Lausanne) : 103
    › Primary publication · 29740578 (PubMed) · PMC5925609 (PubMed Central)
  7. Blocking TGF- and -Catenin Epithelial Crosstalk Exacerbates CKD. Nlandu-Khodo S, Neelisetty S, Phillips M, Manolopoulou M, Bhave G, May L, Clark PE, Yang H, Fogo AB, Harris RC, Taketo MM, Lee E, Gewin LS (2017) J Am Soc Nephrol 28(12): 3490-3503
    › Primary publication · 28701516 (PubMed) · PMC5698068 (PubMed Central)
  8. Role of Hypohalous Acids in Basement Membrane Homeostasis. Colon S, Page-McCaw P, Bhave G (2017) Antioxid Redox Signal 27(12): 839-854
    › Primary publication · 28657332 (PubMed) · PMC5647493 (PubMed Central)
  9. The sulfilimine cross-link of collagen IV contributes to kidney tubular basement membrane stiffness. Bhave G, Colon S, Ferrell N (2017) Am J Physiol Renal Physiol 313(3): F596-F602
    › Primary publication · 28424209 (PubMed) · PMC5625101 (PubMed Central)
  10. Both Drosophila matrix metalloproteinases have released and membrane-tethered forms but have different substrates. LaFever KS, Wang X, Page-McCaw P, Bhave G, Page-McCaw A (2017) Sci Rep : 44560
    › Primary publication · 28300207 (PubMed) · PMC5353688 (PubMed Central)
  11. Basement membrane ultrastructure and component localization data from uterine tissues during early mouse pregnancy. Jones-Paris CR, Paria S, Berg T, Saus J, Bhave G, Paria BC, Hudson BG (2016) Data Brief : 931-939
    › Primary publication · 27896299 (PubMed) · PMC5118616 (PubMed Central)
  12. Proprotein Convertase Processing Enhances Peroxidasin Activity to Reinforce Collagen IV. Colon S, Bhave G (2016) J Biol Chem 291(46): 24009-24016
    › Primary publication · 27697841 (PubMed) · PMC5104926 (PubMed Central)
  13. Embryo implantation triggers dynamic spatiotemporal expression of the basement membrane toolkit during uterine reprogramming. Jones-Paris CR, Paria S, Berg T, Saus J, Bhave G, Paria BC, Hudson BG (2017) Matrix Biol : 347-365
    › Primary publication · 27619726 (PubMed) · PMC5328942 (PubMed Central)
  14. Extracellular chloride signals collagen IV network assembly during basement membrane formation. Cummings CF, Pedchenko V, Brown KL, Colon S, Rafi M, Jones-Paris C, Pokydeshava E, Liu M, Pastor-Pareja JC, Stothers C, Ero-Tolliver IA, McCall AS, Vanacore R, Bhave G, Santoro S, Blackwell TS, Zent R, Pozzi A, Hudson BG (2016) J Cell Biol 213(4): 479-94
    › Primary publication · 27216258 (PubMed) · PMC4878091 (PubMed Central)
  15. The Ancient Immunoglobulin Domains of Peroxidasin Are Required to Form Sulfilimine Cross-links in Collagen IV. Ero-Tolliver IA, Hudson BG, Bhave G (2015) J Biol Chem 290(35): 21741-8
    › Primary publication · 26178375 (PubMed) · PMC4571896 (PubMed Central)
  16. Bromine is an essential trace element for assembly of collagen IV scaffolds in tissue development and architecture. McCall AS, Cummings CF, Bhave G, Vanacore R, Page-McCaw A, Hudson BG (2014) Cell 157(6): 1380-1392
    › Primary publication · 24906154 (PubMed) · PMC4144415 (PubMed Central)
  17. A unique covalent bond in basement membrane is a primordial innovation for tissue evolution. Fidler AL, Vanacore RM, Chetyrkin SV, Pedchenko VK, Bhave G, Yin VP, Stothers CL, Rose KL, McDonald WH, Clark TA, Borza DB, Steele RE, Ivy MT, Aspirnauts, Hudson JK, Hudson BG (2014) Proc Natl Acad Sci U S A 111(1): 331-6
    › Primary publication · 24344311 (PubMed) · PMC3890831 (PubMed Central)
  18. Adverse drug events during AKI and its recovery. Cox ZL, McCoy AB, Matheny ME, Bhave G, Peterson NB, Siew ED, Lewis J, Danciu I, Bian A, Shintani A, Ikizler TA, Neal EB, Peterson JF (2013) Clin J Am Soc Nephrol 8(7): 1070-8
    › Primary publication · 23539228 (PubMed) · PMC3700703 (PubMed Central)
  19. Peroxidasin forms sulfilimine chemical bonds using hypohalous acids in tissue genesis. Bhave G, Cummings CF, Vanacore RM, Kumagai-Cresse C, Ero-Tolliver IA, Rafi M, Kang JS, Pedchenko V, Fessler LI, Fessler JH, Hudson BG (2012) Nat Chem Biol 8(9): 784-90
    › Primary publication · 22842973 (PubMed) · PMC4128002 (PubMed Central)
  20. Real-time pharmacy surveillance and clinical decision support to reduce adverse drug events in acute kidney injury: a randomized, controlled trial. McCoy AB, Cox ZL, Neal EB, Waitman LR, Peterson NB, Bhave G, Siew ED, Danciu I, Lewis JB, Peterson JF (2012) Appl Clin Inform 3(2): 221-238
    › Primary publication · 22719796 (PubMed) · PMC3377180 (PubMed Central)
  21. Body fluid dynamics: back to the future. Bhave G, Neilson EG (2011) J Am Soc Nephrol 22(12): 2166-81
    › Primary publication · 22034644 (PubMed) · PMC4096826 (PubMed Central)
  22. Volume depletion versus dehydration: how understanding the difference can guide therapy. Bhave G, Neilson EG (2011) Am J Kidney Dis 58(2): 302-9
    › Primary publication · 21705120 (PubMed) · PMC4096820 (PubMed Central)
  23. Sulphilimine cross-links in Goodpasture's disease. Vanacore R, Pedchenko V, Bhave G, Hudson BG (2011) Clin Exp Immunol : 4-6
    › Primary publication · 21447121 (PubMed) · PMC3095855 (PubMed Central)
  24. Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel. Bhave G, Chauder BA, Liu W, Dawson ES, Kadakia R, Nguyen TT, Lewis LM, Meiler J, Weaver CD, Satlin LM, Lindsley CW, Denton JS (2011) Mol Pharmacol 79(1): 42-50
    › Primary publication · 20926757 (PubMed) · PMC3014278 (PubMed Central)
  25. Small-molecule modulators of inward rectifier K+ channels: recent advances and future possibilities. Bhave G, Lonergan D, Chauder BA, Denton JS (2010) Future Med Chem 2(5): 757-74
    › Primary publication · 20543968 (PubMed) · PMC2883187 (PubMed Central)
  26. High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1. Lewis LM, Bhave G, Chauder BA, Banerjee S, Lornsen KA, Redha R, Fallen K, Lindsley CW, Weaver CD, Denton JS (2009) Mol Pharmacol 76(5): 1094-103
    › Primary publication · 19706730 (PubMed) · PMC2774996 (PubMed Central)
  27. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis. Bhave G, Lewis JB, Chang SS (2008) J Urol 180(3): 830-5; discussion 835
    › Primary publication · 18635232 (PubMed) · PMC4128001 (PubMed Central)
  28. Posttranslational mechanisms of peripheral sensitization. Bhave G, Gereau RW (2004) J Neurobiol 61(1): 88-106
    › Primary publication · 15362155 (PubMed)
  29. Protein kinase C phosphorylation sensitizes but does not activate the capsaicin receptor transient receptor potential vanilloid 1 (TRPV1). Bhave G, Hu HJ, Glauner KS, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW (2003) Proc Natl Acad Sci U S A 100(21): 12480-5
    › Primary publication · 14523239 (PubMed) · PMC218783 (PubMed Central)
  30. Growing pains: the cytoskeleton as a critical regulator of pain plasticity. Bhave G, Gereau RW (2003) Neuron 39(4): 577-9
    › Primary publication · 12925270 (PubMed)
  31. Membrane topology of a metabotropic glutamate receptor. Bhave G, Nadin BM, Brasier DJ, Glauner KS, Shah RD, Heinemann SF, Karim F, Gereau RW (2003) J Biol Chem 278(32): 30294-301
    › Primary publication · 12764131 (PubMed)
  32. Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5. Neugebauer V, Li W, Bird GC, Bhave G, Gereau RW (2003) J Neurosci 23(1): 52-63
    › Primary publication · 12514201 (PubMed) · PMC6742141 (PubMed Central)
  33. Prostaglandin and protein kinase A-dependent modulation of vanilloid receptor function by metabotropic glutamate receptor 5: potential mechanism for thermal hyperalgesia. Hu HJ, Bhave G, Gereau RW (2002) J Neurosci 22(17): 7444-52
    › Primary publication · 12196566 (PubMed) · PMC6757997 (PubMed Central)
  34. cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW (2002) Neuron 35(4): 721-31
    › Primary publication · 12194871 (PubMed)
  35. Metabotropic glutamate receptors on peripheral sensory neuron terminals as targets for the development of novel analgesics. Karim F, Bhave G, Gereau RW (2001) Mol Psychiatry 6(6): 615-7
    › Primary publication · 11673787 (PubMed)
  36. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Bhave G, Karim F, Carlton SM, Gereau RW (2001) Nat Neurosci 4(4): 417-23
    › Primary publication · 11276233 (PubMed)